Henry; Rodger F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Henry; Rodger F..The latest application filed is for "methods of treating parkinson's disease".
Company Profile
2.21.42
- Henry; Rodger F. - Wildwood IL
- Henry; Rodger F. - Park City IL
Patent Activity
| Patent | Date |
|---|---|
| Methods Of Treating Parkinson's Disease App 20220153765 - Cardinal-David; Benoit ; et al. | 2022-05-19 |
| Carbidopa Prodrugs App 20200262852 - Cardinal-David; Benoit ; et al. | 2020-08-20 |
| Carbidopa Prodrug App 20190375770 - Cardinal-David; Benoit ; et al. | 2019-12-12 |
| Carbidopa and L-Dopa Prodrugs and Methods of use App 20180079762 - Cardinal-David; Benoit ; et al. | 2018-03-22 |
| Carbidopa And L-Dopa Prodrugs And Methods Of Use App 20160362431 - CARDINAL-DAVID; Benoit ; et al. | 2016-12-15 |
| Carbidopa and L-dopa prodrugs and methods of use Grant 9,446,059 - Cardinal-David , et al. September 20, 2 | 2016-09-20 |
| Carbidopa and L-Dopa Prodrugs and Methods of Use App 20160106765 - CARDINAL-DAVID; Benoit ; et al. | 2016-04-21 |
| Azaadamantane Derivatives And Methods Of Use App 20150158867 - Schrimpf; Michael R. ; et al. | 2015-06-11 |
| Azaadamantane derivatives and methods of use Grant 8,987,453 - Schrimpf , et al. March 24, 2 | 2015-03-24 |
| Anti-infective agents and uses thereof Grant 8,986,740 - Donner , et al. March 24, 2 | 2015-03-24 |
| Crystalline Pharmaceutical App 20140303369 - Dickman; Daniel A. ; et al. | 2014-10-09 |
| Crystalline pharmaceutical Grant 8,796,451 - Dickman , et al. August 5, 2 | 2014-08-05 |
| Azaadamantane Derivatives And Methods Of Use App 20130096132 - Schrimpf; Michael R. ; et al. | 2013-04-18 |
| Octahydro-pyrrolo[3,4-B]pyrrole derivatives Grant 8,399,468 - Cowart , et al. March 19, 2 | 2013-03-19 |
| Azaadamantane derivatives and methods of use Grant 8,314,119 - Schrimpf , et al. November 20, 2 | 2012-11-20 |
| Anti-infective Agents And Uses Thereof App 20120189580 - Donner; Pamela L. ; et al. | 2012-07-26 |
| Anti-infective agents and uses thereof Grant 8,178,548 - Donner , et al. May 15, 2 | 2012-05-15 |
| Crystalline Pharmaceutical App 20110281900 - Dickman; Daniel A. ; et al. | 2011-11-17 |
| Crystalline pharmaceutical Grant 8,058,433 - Dickman , et al. November 15, 2 | 2011-11-15 |
| Crystalline chemotherapeutic Grant 7,943,782 - Henry May 17, 2 | 2011-05-17 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20100222358 - Cowart; Marlon D. ; et al. | 2010-09-02 |
| Crystalline Lestaurtinib Hydrates And Crystalline Lestaurtinib Hemihydrate Hemiacetonitrileate And Crystalline Lestaurtinib Hemihydrate Hemitetrahydrofuranate App 20100048534 - Dziki; Walter ; et al. | 2010-02-25 |
| Lestaurtinib Crystalline Form 1, Crystalline Lestaurimib Anhydrate And Amorphous Lestaurimib App 20100048533 - Dziki; Walter ; et al. | 2010-02-25 |
| Crystalline k-252b, sodium salt, methanolate pentahydrate Grant 7,589,194 - Henry September 15, 2 | 2009-09-15 |
| Crystalline K-252.alpha. bis(tetrahydrofuranate) Grant 7,585,972 - Henry September 8, 2 | 2009-09-08 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- Diazabicyclo[3.2.0]heptane App 20090203664 - Buckley; Michael J. ; et al. | 2009-08-13 |
| Anti-infective Agents And Uses Thereof App 20090176784 - Donner; Pamela L. ; et al. | 2009-07-09 |
| (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane Grant 7,538,226 - Buckley , et al. May 26, 2 | 2009-05-26 |
| Crystalline Chemotherapeutic App 20090105326 - Henry; Rodger F. | 2009-04-23 |
| Crystalline Chemotherapeutic App 20090105486 - Henry; Rodger F. | 2009-04-23 |
| N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1 Grant 7,449,584 - Schmitt , et al. November 11, 2 | 2008-11-11 |
| N-((2Z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 Grant 7,446,206 - Schmitt , et al. November 4, 2 | 2008-11-04 |
| CRYSTALLINE K-252b, SODIUM SALT, HYDRATE App 20080177063 - Henry; Rodger F. | 2008-07-24 |
| CRYSTALLINE K-252a BIS(N,N' DIMETHYLFORMAMIDATE) App 20080177062 - Henry; Rodger F. | 2008-07-24 |
| CRYSTALLINE K-252a BIS(TETRAHYDROFURANATE) App 20080171867 - Henry; Rodger F. | 2008-07-17 |
| CRYSTALLINE K-252a BIS(METHANOLATE) App 20080171866 - Henry; Rodger F. | 2008-07-17 |
| CRYSTALLINE K-252b, SODIUM SALT, METHANOLATE PENTAHYDRATE App 20080171868 - Henry; Rodger F. | 2008-07-17 |
| Azaadamantane Derivatives And Methods Of Use App 20080167336 - Schrimpf; Michael R. ; et al. | 2008-07-10 |
| Atrasentan Hydrochloride Crystalline Form 2 App 20080132710 - Henry; Rodger F. ; et al. | 2008-06-05 |
| (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane Grant 7,354,937 - Buckley , et al. April 8, 2 | 2008-04-08 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane App 20080070891 - Buckley; Michael J. ; et al. | 2008-03-20 |
| Octahydro-pyrrolo[3,4-b]pyrrole Derivatives App 20070232612 - Cowart; Marlon D. ; et al. | 2007-10-04 |
| Lestaurtinib Crystalline Form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib App 20070135401 - Dziki; Walter ; et al. | 2007-06-14 |
| Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate App 20070135628 - Dziki; Walter ; et al. | 2007-06-14 |
| N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide crystalline form 1 App 20070099967 - Schmitt; Eric A. ; et al. | 2007-05-03 |
| N-((2Z)-2-((4-Hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2 App 20070004782 - Schmitt; Eric A. ; et al. | 2007-01-04 |
| Crystalline anhydrous cefdinir and crystalline cefdinir hydrates App 20060287289 - Law; Devalina ; et al. | 2006-12-21 |
| Crystalline anhydrous cefdinir and crystalline cefdinir hydrates App 20060211676 - Law; Devalina ; et al. | 2006-09-21 |
| Crystalline anhydrous cefdinir and crystalline cefdinir hydrates App 20060142261 - Law; Devalina ; et al. | 2006-06-29 |
| Crystalline anhydrous cefdinir and crystalline cefdinir hydrates App 20060142563 - Law; Devalina ; et al. | 2006-06-29 |
| (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane App 20060035936 - Buckley; Michael J. ; et al. | 2006-02-16 |
| Crystalline anhydrous cefdinir and crystalline cefdinir hydrates App 20060025399 - Law; Devalina ; et al. | 2006-02-02 |
| 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyr- idazin-3-one salts and their preparation App 20050256127 - Ku, Yi-Yin ; et al. | 2005-11-17 |
| Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir App 20050209211 - Law, Devalina ; et al. | 2005-09-22 |
| Crystalline pharmaceutical App 20050124810 - Dickman, Daniel A. ; et al. | 2005-06-09 |
| Crystalline pharmaceutical Grant 6,864,369 - Dickman , et al. March 8, 2 | 2005-03-08 |
| Crystalline pharmaceutical App 20030191313 - Dickman, Daniel A. ; et al. | 2003-10-09 |
| 6-O-methylerythromycin A crystal form III Grant 6,627,743 - Liu , et al. September 30, 2 | 2003-09-30 |
| Crystalline pharmaceutical Grant 6,608,198 - Dickman , et al. August 19, 2 | 2003-08-19 |
| Crystalline pharmaceutical App 20010051721 - Dickman, Daniel A. ; et al. | 2001-12-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 